research and development
Phillipe Lutz joins Telormedix
May 13, 2010Research and Development appointment, research and development, telormedix
Swiss clinical stage biopharmaceutical company Telormedix has appointed Phillipe Lutz chief financial officer. He joins the company from Synosia Therapeutics, …
GSK appoints Patrick Vallance
May 12, 2010Research and Development GSK, appointment, research and development
Patrick Vallance has been appointed as senior vice president, medicines discovery and development at GlaxoSmithKline, and as a member of …
Synexus appoints Germany and Poland managers
May 11, 2010Research and Development CRO, Synexus, appointment, research and development
Synexus has appointed Dr Helena Sigal as country manager for Germany and Radoslaw Janiak as country manager for Poland. Helena …
Professor Sander van Deventer appointed to AMT supervisory board
May 10, 2010Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development
Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …
Merck separates president role, appoints Kenneth Frazier
April 30, 2010Manufacturing and Production, Research and Development, Sales and Marketing Merck & Co, appointment, manufacturing and production, research and development, sales and marketing
Merck & Co has partially split the joint roles of chairman, chief executive and president currently held by Richard Clark, …
US pharma execs join Algeta board
April 29, 2010Research and Development Algeta, appointment, research and development
Oslo-based oncology company Algeta has added Judith Hemberger and Kapil Dhingra to its board of directors. Judith Hemberger has more …
Bayer lures Novartis’ Reinhardt for top healthcare post
April 22, 2010Research and Development, Sales and Marketing Bayer, appointment, research and development, sales and marketing
German pharma company Bayer has ended its search for someone to replace healthcare chief executive Arthur Higgins, appointing Dr Jörg …
Action Pharma appoints new chief executive
April 19, 2010Research and Development Action Pharma, appointment, research and development
Ingelise Saunders has joined Danish biotech Action Pharma as its new chief executive. She will be involved in seeking partners …
Dr Simon Best joins Aquapharm as chief executive
April 13, 2010Research and Development Aquapharm, Aquapharm Biodiscovery, appointment, research and development
Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current …
Frank Pitzer made chief executive at NimbleGen
April 7, 2010Research and Development NimbleGen, Roche, appointment, research and development
Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …
Obituary: Sir James Black
April 6, 2010Research and Development appointment, research and development
Sir James Black, the British physician and pharmacologist who discovered some of the biggest breakthroughs in medicine in the 20th …
Cordis appoints Christian Spaulding
March 30, 2010Cordis, Johnson & Johnson, appointment, research and development
Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …
Pfizer’s Kindler elected PhRMA chairman
March 22, 2010Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing
Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …
Talking Point: Responding to trial emergencies
March 19, 2010Research and Development Talking Point, Talking R&D, research and development
Patients taking part in a clinical trial will sometimes experience a medical emergency, at which point the potential need to …
Bill Burns joins Shire board
March 17, 2010Research and Development, Sales and Marketing Shire, appointment, research and development, sales and marketing
Former Roche pharma chief executive Bill Burns has joined the board at Shire as a non-executive director. Burns has also …
